Live Quote · NASDAQAUPHHealthcare· Biotechnology

Aurinia Pharmaceuticals Inc.

$14.70▼ 1.28%($-0.19)
MKT CAP $1.97BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
79/100
▌ Solid
80
Valuation
100
Profitability
95
Growth
92
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AUPH research report →

Analyst Price Target
$17.00+15.6% vs. today

Range $16 – $18

Analyst RatingBuy
12 Buy4 Hold0 Sell

Price Chart

-1.46% · this period
$18.62$16.29$13.95Nov 20May 26Nov 20
52-Week Range21% of range
Low
$13.52
Current
$14.70
High
$19.25